Each vial meets USP specifications for sterility, endotoxin limits, and particulate matter, ensuring consistent and reliable performance in research applications
Persistent nausea and vomiting : Especially if unable to keep down fluids, raising dehydration concerns
14.2 BYDUREON BCISE Glycemic Control Trials in Adults with Type 2 Diabetes Mellitus BYDUREON BCISE versus BYETTA, Both as Monotherapy or as Add-on to Metformin, a Sulfonylurea, a Thiazolidinedione, or Combination of Oral Agents A 28-week, randomized, open-label comparator-controlled trial was conducted to compare the safety and efficacy of BYDUREON BCISE to BYETTA in adult patients with type 2 diabetes and inadequate glycemic control with diet and exercise alone or with oral antidiabetic therapy, including metformin, a sulfonylurea, a thiazolidinedione, or a combination of any two of these therapies (Trial 1 - NCT01652716)
Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency
Oral versions require specific stomach pH conditions and intact intestinal lining for optimal absorption
